Tirzepatide is an FDA-approved dual GIP/GLP-1 receptor agonist proven effective for type 2 diabetes and chronic weight management, while Lipo C refers to unapproved compounded lipotropic injections containing methionine, inositol, choline, and vitamin B12
Graul AI, Stringer M, Sorbera L
While mild transaminase elevations are typically dose-related, clinically significant hepatotoxicity is largely idiosyncratic and unpredictable
Alcoholism, malabsorption, prolonged stress, tapeworm infestation, vegan diets, celiac, hyperthyroidism, hepatic-biliary tract disease, persistent diarrhea, ileal resection, pancreatic cancer, renal disease, macrobiotic diets or other restrictive diets
Alzheimers & Dementia, July 2018, Vol 14, Issue 7, Suppl, P1523
Elinor Huntsman, and Jessie H